Polyclonal autoantibodies against human GM-CSF (granulocyte/macrophage colony-stimulating factor) are a hallmark of PAP (pulmonary alveolar proteinosis) and several other reported autoimmune diseases. MB007 is a high-affinity anti-(human GM-CSF) autoantibody isolated from a patient suffering from PAP which shows only modest neutralization of GM-CSF bioactivity. We describe the first crystal structure of a cytokine-directed human IgG1λ autoantibody-binding fragment (Fab) at 1.9 Å (1 Å=0.1 nm) resolution. Its CDR3-H substantially differs from all VH7 germline IgG1 structures reported previously. We derive a reliable model of the antigen–autoantibody complex by using NMR chemical shift perturbation data in combination with computational methods. Superposition of the modelled complex structure with the human GM-CSF–GM-CSF ternary receptor complex reveals only little overlap between receptor and Fab when bound to GM-CSF. Our model provides a structural basis for understanding the mode of action of the MB007 autoantibody.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
October 2012
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
September 26 2012
Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications Available to Purchase
Michaela Blech;
Michaela Blech
1
*Department of Lead Identification and Optimization Support, Structural Research Group, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach, Germany
†Department of NBE Discovery, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach, Germany
‡Institut für Medizintechnologie der Ruprecht-Karls-Universität Heidelberg & Hochschule Mannheim, Heidelberg and Mannheim, Germany
1Correspondence may be addressed to either of these authors (email [email protected] or [email protected]).
Search for other works by this author on:
Daniel Seeliger;
Daniel Seeliger
§Department of Lead Identification and Optimization Support, Computational Chemistry Group, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach, Germany
Search for other works by this author on:
Barbara Kistler;
Barbara Kistler
∥Department of Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach, Germany
Search for other works by this author on:
Margit M. T. Bauer;
Margit M. T. Bauer
*Department of Lead Identification and Optimization Support, Structural Research Group, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach, Germany
Search for other works by this author on:
Mathias Hafner;
Mathias Hafner
‡Institut für Medizintechnologie der Ruprecht-Karls-Universität Heidelberg & Hochschule Mannheim, Heidelberg and Mannheim, Germany
Search for other works by this author on:
Stefan Hörer;
Stefan Hörer
*Department of Lead Identification and Optimization Support, Structural Research Group, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach, Germany
Search for other works by this author on:
Markus Zeeb;
Markus Zeeb
*Department of Lead Identification and Optimization Support, Structural Research Group, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach, Germany
Search for other works by this author on:
Herbert Nar;
Herbert Nar
*Department of Lead Identification and Optimization Support, Structural Research Group, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach, Germany
Search for other works by this author on:
John E. Park
John E. Park
1
†Department of NBE Discovery, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach, Germany
1Correspondence may be addressed to either of these authors (email [email protected] or [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
May 30 2012
Revision Received:
July 10 2012
Accepted:
July 27 2012
Accepted Manuscript online:
July 27 2012
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2012 Biochemical Society
2012
Biochem J (2012) 447 (2): 205–215.
Article history
Received:
May 30 2012
Revision Received:
July 10 2012
Accepted:
July 27 2012
Accepted Manuscript online:
July 27 2012
Citation
Michaela Blech, Daniel Seeliger, Barbara Kistler, Margit M. T. Bauer, Mathias Hafner, Stefan Hörer, Markus Zeeb, Herbert Nar, John E. Park; Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications. Biochem J 15 October 2012; 447 (2): 205–215. doi: https://doi.org/10.1042/BJ20120884
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |